Plus, news about Adaptimmune, Roche, LIfT BioSciences, VerImmune, and Revance Therapeutics:
Capricor Therapeutics to file Duchenne cardiomyopathy treatment with the FDA: The San Diego-based biotech …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
In the wake of the Supreme Court’s decision to preserve access to mifepristone (Mifeprex) on Thursday, abortion-rights groups worry the threat has not passed while
A China-developed KRAS inhibitor led to objective responses in half of patients with previously treated KRAS-mutant non-small cell lung cancer (NSCLC), a prospective non-randomized trial
Facilitator Licensing & Training DORA’s first set of rules, released in April, mark the first rules for Colorado’s regulated Natural Medicine program to become official.